(For treatment side effects and complications only)
Qualifications: MB, ChB (Hons) MRCP FRCPath AFHEA
GMC number: 6052663
Clinics: Royal Liverpool University Hospital
Tumour site(s): Lymphoid malignancy
Dr Arumainathan did his undergraduate training at the University of Liverpool. The majority of his postgraduate training was in the Mersey region. His primary clinical focus is lymphoid malignancy - lymphoma and chronic lymphocytic leukaemia (CLL) - and he has a clinical interest in lymphoma in the setting of immune deficiency. He is the currently the lead for the Trust's Lymphoma Site Reference Group.
Dr Arumainathan participates actively in clinical research and is the local principal investigator for several studies. He is also a clinical co-ordinator for national lymphoma/CLL trials at the Liverpool Cancer Trials Unit. He has been the clinical lead for the integration of haemato-oncology into Clatterbridge since 2015.